Development
Alnylam Pharmaceuticals, Inc.
ALNY
$300.83
-$7.17-2.33%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.44B | 2.41B | 2.06B | 2.07B | 2.19B |
| Total Receivables | 327.79M | 325.45M | 220.64M | 219.43M | 237.96M |
| Inventory | 89.15M | 95.77M | 100.45M | 131.88M | 128.96M |
| Prepaid Expenses | 126.38M | 157.96M | 145.45M | 119.03M | 132.92M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.98B | 2.99B | 2.52B | 2.54B | 2.69B |
|
|
|||||
| Total Current Assets | 2.98B | 2.99B | 2.52B | 2.54B | 2.69B |
| Net Property, Plant & Equipment | 725.79M | 729.08M | 736.28M | 738.08M | 738.63M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 121.39M | 124.55M | 142.07M | 112.84M | 115.48M |
| Total Assets | 3.83B | 3.84B | 3.40B | 3.39B | 3.55B |
|
|
|||||
| Total Accounts Payable | 55.52M | 73.84M | 59.75M | 62.24M | 98.09M |
| Total Accrued Expenses | 654.73M | 713.09M | 598.53M | 508.60M | 513.78M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 96.50M | 85.71M | 75.72M | 66.76M | 82.26M |
| Total Finance Division Other Current Liabilities | 161.04M | 77.14M | 54.64M | 35.79M | 73.79M |
| Total Other Current Liabilities | 161.04M | 77.14M | 54.64M | 35.79M | 73.79M |
| Total Current Liabilities | 967.79M | 949.79M | 788.64M | 673.39M | 767.92M |
|
|
|||||
| Total Current Liabilities | 967.79M | 949.79M | 788.64M | 673.39M | 767.92M |
| Long-Term Debt | 2.34B | 2.33B | 2.32B | 2.30B | 2.27B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 243.10M | 247.71M | 253.42M | 259.40M | 261.34M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 496.61M | 476.82M | 451.18M | 415.30M | 406.37M |
| Total Liabilities | 4.05B | 4.00B | 3.81B | 3.65B | 3.70B |
|
|
|||||
| Common Stock & APIC | 6.81B | 6.74B | 6.65B | 6.52B | 6.46B |
| Retained Earnings | -7.01B | -6.87B | -7.02B | -6.74B | -6.57B |
| Treasury Stock & Other | -23.38M | -32.34M | -37.08M | -39.12M | -44.65M |
| Total Common Equity | -220.64M | -165.87M | -408.13M | -259.24M | -158.22M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -220.64M | -165.87M | -408.13M | -259.24M | -158.22M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -220.64M | -165.87M | -408.13M | -259.24M | -158.22M |
|
|
|||||